Clinical Trials Directory

Trials / Unknown

UnknownNCT03171974

Ultrasound Guided Treatment of Steroids for Capsular Contracture in Patients With Reconstructed/Augmented Breast

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Rabin Medical Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Ultrasound guided treatment of steroids for capsular contracture in patients with reconstructed/augmented breast

Detailed description

The aim of this study is to evaluate ultrasound (US)-guided treatment of capsular contracture (CC) in patients with reconstructed/ augmented breast. Capsular contraction is the one of the most common complications of both esthetic and reconstructive breast surgery with an incidence of 0.5-30% and 1-38%, respectively. In irradiated patients the incidence is higher, in the range of 30-67%. It appears most commonly in the first year but in some patients, belated capsular contracture has been noticed. The more severe forms of contraction, Baker grades 3 and 4 with a firm often deformed and painful breast, have been shown to recur as often as 67% after capsulotomy steroid injection has been demonstrated to be effective for the treatment of this condition. 20-30 female with grade III\\IV CC will be included. Patients will be treated with peri-implant US-guided injection of Dexamethasone The purpose of our study is to use a longer acting steroid (Dexamethasone) injected intra capsular with US-guide. By that getting a better effect on the level of fibrosis. This Clinical study will be conducted in the tertiary academic Rabin Medical Center. Several measures will be taken, including: capsular contracture grading by two plastic surgeons, a VAS-score of breast pain, maximal capsular thickness (MCT) in sonography

Conditions

Interventions

TypeNameDescription
DRUGDexamethasonedexamethasone will be injected intracapsular under US
DEVICEUSdexamethasone will be injected intracapsular under US

Timeline

Start date
2017-10-01
Primary completion
2019-08-01
Completion
2019-12-01
First posted
2017-05-31
Last updated
2017-10-03

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03171974. Inclusion in this directory is not an endorsement.